Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. [electronic resource]
- Journal of cardiovascular pharmacology Jan 2008
- 45-54 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't